National Hospital Organization Kyushu Cancer Center

Minamiku 811-1395

0 studies enrolling now · 2 studies all time

What they study most

Locally Advanced or Unresectable Metastatic Breast Cancer, PD-L1 Negative, Stage IV Breast Cancer, Triple Negative Breast Cancer

Studies at this site

• Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer — Running, not enrolling
• Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer Who Have Received Endocrine Therapy — Running, not enrolling